ARCHIVES

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

Panel Tells Carter Cancer Program Needs More Money

March 4, 1977

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

“We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board

January 1, 1993